skip to Main Content

Investors

Qualisure Diagnostics Inc.

Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists to personalize treatments. Each of our biomarkers is designed to influence clinical decision-making and to facilitate Precision Medicine. Our precision diagnostics – discovered using our own machine learning algorithms – minimize the burden of cancer treatment by avoiding toxic and costly treatments that are unlikely to provide benefit.

Investor Login